Privia (NASDAQ: PRVA) CFO sells 13,058 shares via 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Privia Health Group EVP & CFO David Mountcastle exercised fully vested stock options and sold shares under a pre-established Rule 10b5-1 trading plan. On February 26 and 27, he exercised options to receive common stock at an exercise price of $2.00 per share and then sold 13,058 shares of common stock in open-market transactions at weighted average prices around $25 per share, according to price ranges disclosed in the footnotes. After these transactions, he directly owns 172,909 shares of Privia common stock and indirectly owns 8,695 shares through his spouse.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 13,058 shares ($326,835)
Net Sell
13 txns
Insider
Mountcastle David
Role
EVP & Chief Financial Officer
Sold
13,058 shs ($327K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Purchase) | 998 | $0.00 | -- |
| Exercise | Stock Option (Right to Purchase) | 2,699 | $0.00 | -- |
| Exercise | Stock Option (Right to Purchase) | 3,428 | $0.00 | -- |
| Exercise | Stock Option (Right to Purchase) | 572 | $0.00 | -- |
| Exercise | Common Stock, par value $0.01 per share | 7,697 | $2.00 | $15K |
| Sale | Common Stock, par value $0.01 per share | 7,697 | $25.05 | $193K |
| Exercise | Stock Option (Right to Purchase) | 1,668 | $0.00 | -- |
| Exercise | Stock Option (Right to Purchase) | 1,100 | $0.00 | -- |
| Exercise | Stock Option (Right to Purchase) | 1,893 | $0.00 | -- |
| Exercise | Stock Option (Right to Purchase) | 700 | $0.00 | -- |
| Exercise | Common Stock, par value $0.01 per share | 5,361 | $2.00 | $11K |
| Sale | Common Stock, par value $0.01 per share | 5,361 | $25.00 | $134K |
| holding | Common Stock, $0.01 par value per share | -- | -- | -- |
Holdings After Transaction:
Stock Option (Right to Purchase) — 2,835 shares (Direct);
Common Stock, par value $0.01 per share — 180,606 shares (Direct);
Common Stock, $0.01 par value per share — 8,695 shares (Indirect, By spouse)
Footnotes (1)
- This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.02 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.19 per share. The reporting person undertakes to provide to Privia Health Group, Inc., any security holder of Privia Health Group, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. All of the stock options are fully vested and exercisable.
FAQ
What did Privia Health (PRVA) CFO David Mountcastle report in this Form 4?
Privia Health’s CFO David Mountcastle reported exercising stock options and selling shares. He exercised options at an exercise price of $2.00 per share, then sold 13,058 shares in open-market transactions under a Rule 10b5-1 trading plan.
What stock options did the Privia Health (PRVA) CFO exercise in this filing?
The CFO exercised multiple fully vested stock options described as “Stock Option (Right to Purchase).” A footnote clarifies that all of these options are fully vested and exercisable, and several of the resulting shares carried an exercise price of $2.00.
Does the Form 4 show any indirect Privia Health (PRVA) holdings for the CFO?
Yes. The Form 4 discloses indirect ownership of 8,695 shares of common stock characterized as held “By spouse.” These shares are reported separately from the CFO’s directly owned 172,909 shares of Privia Health common stock.